Journal of Clinical Endocrinology and Metabolism

Journal

Publication Venue For

  • Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.  108:706-712. 2023
  • Pharmacologic Weight Management in the Era of Adolescent Obesity.  107:2716-2728. 2022
  • Changes in Type 2 Diabetes Trends in Children and Adolescents During the COVID-19 Pandemic.  107:E2777-E2782. 2022
  • C-reactive Protein and Racial Differences in Type 2 Diabetes Incidence: The REGARDS Study.  107:E2523-E2531. 2022
  • Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India.  107:E2267-E2275. 2022
  • PCOS and Mendelian Randomization: Too Soon?.  107:E2195-E2196. 2022
  • New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications..  107:e1339-e1347. 2022
  • Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.  107:E912-E923. 2022
  • Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.  107:575-585. 2022
  • Insulin Resistance and Cardiometabolic Risk Profile among Nondiabetic American Young Adults: Insights from NHANES.  107:E25-E37. 2022
  • Case Studies in Pediatric Lipid Disorders and Their Management.  106:3605-3620. 2021
  • Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients without Diabetes.  106:E4360-E4371. 2021
  • Proinsulin to C-Peptide Ratio in the First Year after Diagnosis of Type 1 Diabetes.  106:E4318-E4326. 2021
  • Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.  106:E3483-E3494. 2021
  • The Association of Lactation Duration with Visceral and Pericardial Fat Volumes in Parous Women: The CARDIA Study.  106:1821-1831. 2021
  • Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS.  106:E2151-E2161. 2021
  • Long-term change in physiological markers and cognitive performance in type 2 diabetes: The look ahead study.  105. 2020
  • Race, ancestry, and Vitamin D metabolism: The multi-ethnic study of atherosclerosis.  105. 2020
  • Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction.  105. 2020
  • Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study..  105:e3400-e3414. 2020
  • Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations".  105. 2020
  • Adipocyte insulin resistance in PCOS: Relationship with GLUT-4 expression and whole-body glucose disposal and β-cell function.  105. 2020
  • Biomarkers and noncalcified coronary artery plaque progression in older men treated with testosterone.  105. 2020
  • Prostate-Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.  104:6238-6246. 2019
  • Improving Long-Term Outcomes of Youth with Lipid Abnormalities - Expanding the Role of Pediatric Endocrinologists.  104:4421-4426. 2019
  • JC viruria is associated with reduced risk of diabetic kidney disease.  104:2286-2294. 2019
  • Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee.  104:2875-2891. 2019
  • The effect of testosterone on cardiovascular biomarkers in the testosterone trials.  103:681-688. 2018
  • ACTIVExtend: 24 Months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis.  103:2949-2957. 2018
  • Letter to the Editor: “Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis”.  102:3865-3866. 2017
  • The relationship between the score on a simple measure of cognitive function and incident CVD in people with diabetes: A post hoc epidemiological analysis from the accord-mind study.  102:3218-3225. 2017
  • No increase in fractures after stopping hormone therapy: Results from the women's health initiative.  102:302-308. 2017
  • Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?.  102:4421-4427. 2017
  • Triglyceride levels and fracture risk in midlife women: Study of women's health across the nation (SWAN).  101:3297-3305. 2016
  • Testosterone treatment and sexual function in older men with low testosterone levels.  101:3096-3104. 2016
  • Erratum: Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and B cell function in overweight adults (J Clin Endocrinol (2013) 98:7 (E1173-E1180) doi: 10.1210/jc.2013-1203).  101:2265. 2016
  • Vitamin D supplementation modulates t cell-mediated immunity in humans: Results from a randomized control trial.  101:533-538. 2016
  • Bone mineral density as a predictor of subsequent wrist fractures: Findings from the women's health initiative study.  100:4315-4324. 2015
  • Impact of phosphorus-based food additives on bone and mineral metabolism.  100:4264-4271. 2015
  • Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes.  100:3871-3877. 2015
  • Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.  100:1146-1155. 2015
  • Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al.  100. 2015
  • Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals.  100:E182-E186. 2015
  • The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.  99:E2754-E2761. 2014
  • Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).  99:817-826. 2014
  • Insulin resistance indices are inversely associated with vitamin D binding protein concentrations.  99:178-183. 2014
  • Polycystic ovary syndrome: What's in a name?.  99:1142-1145. 2014
  • α-Internexin: A novel biomarker for pancreatic neuroendocrine tumor aggressiveness.  99. 2014
  • The severity of menstrual dysfunction as a predictor of insulin resistance in pcos.  98. 2013
  • Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.  98. 2013
  • Hypercortisolism is associated with increased coronary arterial atherosclerosis: Analysis of noninvasive coronary angiography using multidetector computerized tomography.  98:2045-2052. 2013
  • Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.  98:1541-1548. 2013
  • Update on treatment strategies for obesity.  98:1299-1306. 2013
  • 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.  98. 2013
  • Associations of Total and Undercarboxylated Osteocalcin with Peripheral and Hepatic Insulin Sensitivity and β-Cell Function in Overweight Adults.  98. 2013
  • Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.  97:4004-4013. 2012
  • Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.  97. 2012
  • Skeletal muscle lipid peroxidation and insulin resistance in humans.  97. 2012
  • Association of intact parathyroid hormone levels with subsequent hip BMD loss: The Osteoporotic Fractures in Men (MrOS) study.  97:1937-1944. 2012
  • Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.  97. 2012
  • Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: Implications for progesterone actions in human pregnancy and parturition.  97. 2012
  • Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: The CARDIA study.  97:1337-1346. 2012
  • Adolescent diet and metabolic syndrome in young women: Results of the Dietary Intervention Study in Children (DISC) follow-up study.  96. 2011
  • Smad2: A candidate gene for the murine autoimmune diabetes locus Idd21.1.  96. 2011
  • Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjögren's syndrome.  96:3302-3307. 2011
  • Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies.  96:3242-3249. 2011
  • Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with β-cell function.  96. 2011
  • Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism..  96:E1142-E1147. 2011
  • Adiposity, inflammation, and risk for death in black and white men and women in the United States: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  96:1805-1814. 2011
  • Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.  96. 2011
  • Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome.  96. 2011
  • Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered β-cell function.  96. 2011
  • Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160)).  95:5137. 2010
  • Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline.  95:4133-4160. 2010
  • DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  95:4985-4992. 2010
  • Postmenopausal hormone therapy: An endocrine society scientific statement.  95:s1-s66. 2010
  • Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The "coronary artery risk development in young adults" women's study.  95:4424-4431. 2010
  • Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-α.  95:935-942. 2010
  • Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.  95:4625-4634. 2010
  • The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study.  95:4432-4440. 2010
  • Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.  94:3282-3288. 2009
  • Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology.  94:3798-3805. 2009
  • Effect of dietary adherence with or without exercise on weight loss: A mechanistic approach to a global problem.  94:1602-1607. 2009
  • Homocysteine levels and risk of hip Fracture in postmenopausal women.  94:1207-1213. 2009
  • Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.  94:17-20. 2009
  • Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase gene.  94:5034-5038. 2009
  • Loss of rap1GAP in papillary thyroid cancer.  94:1026-1032. 2009
  • Neuropsychological features in primary hyperparathyroidism: A prospective study.  94:1951-1958. 2009
  • Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.  94:1097-1103. 2009
  • Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men.  94:2773-2780. 2009
  • Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents.  94:3200-3206. 2009
  • Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: Comparative efficacy of ergocalciferol, cholecalciferol, and UV light.  94:2037-2043. 2009
  • Vitamin D deficiency in older men.  94:1214-1222. 2009
  • Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.  93:2909-2912. 2008
  • Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.  93:1939-1945. 2008
  • Associations among insulin, estrogen, and fat mass gain over the pubertal transition in African-American and european-american girls.  93:2610-2615. 2008
  • Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women.  93:1796-1803. 2008
  • Changes over 14 years in androgenicity and body mass index in a biracial cohort of reproductive-age women.  93:2158-2165. 2008
  • Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.  93:3785-3793. 2008
  • Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.  93:809-814. 2008
  • Impact of obesity on the risk for polycystic ovary syndrome.  93:162-168. 2008
  • Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents.  93:4917-4923. 2008
  • Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.  93:300-303. 2008
  • Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects (Journal of Clinical Endocrinology and Metabolism 92, (1814-1820)).  93:1082. 2008
  • Polycystic ovary syndrome is a family affair.  93:1579-1581. 2008
  • Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation.  93:1276-1284. 2008
  • Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.  93:4268-4275. 2008
  • Relationship of fat distribution with adipokines in human immunodeficiency virus infection.  93:216-224. 2008
  • Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies.  93:1062-1071. 2008
  • Thyroid hormones directly alter human hair follicle functions: Anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation.  93:4381-4388. 2008
  • Analysis of the Fc receptor-like-3 (FCRL3) locus in caucasians with autoimmune disorders suggests a complex pattern of disease association.  92:1106-1111. 2007
  • Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white women.  92:4730-4733. 2007
  • Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation.  92:1909-1919. 2007
  • Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.  92:2659-2664. 2007
  • Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects.  92:1814-1820. 2007
  • Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement.  92:405-413. 2007
  • Soy isoflavones do not affect bone resorption in postmenopausal women: A dose-response study using a novel approach with41Ca.  92:577-582. 2007
  • Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.  91:2631-2637. 2006
  • Phytoestrogens and lipoproteins in women.  91:2209-2213. 2006
  • A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.  91:1526-1534. 2006
  • Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism.  91:1345-1350. 2006
  • Editorial: Uncoupling protein 3 and human metabolism.  91:1226-1228. 2006
  • Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature.  91:781-785. 2006
  • Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline.  91:4237-4245. 2006
  • Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.  91:48-53. 2006
  • Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.  91:3451-3456. 2006
  • Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.  91:4085-4091. 2006
  • Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study.  90:6072-6076. 2005
  • Erratum: Effects of Aging on Cytochrome B5 Expression in the Human Adrenal Gland (The Journal of Clinical Endocrinology and Metabolism (2005) 90 (4357-4361)).  90:5286. 2005
  • Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.  90:4920-4923. 2005
  • Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span.  90:4650-4658. 2005
  • Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndrome.  90:4852-4857. 2005
  • Effects of aging on cytochrome B5 expression in the human adrenal gland.  90:4357-4361. 2005
  • Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.  90:4350-4356. 2005
  • Voluntary weight reduction in older men increases hip bone loss: The osteoporotic fractures in men study.  90:1998-2004. 2005
  • Association of the intestinal fatty acid-binding protein Ala 54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women.  90:1196-1201. 2005
  • Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: Clinical characterization and exclusion of candidate loci.  90:4025-4034. 2005
  • Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.  90:66-71. 2005
  • Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.  89:5558-5562. 2004
  • Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach.  89:4197-4205. 2004
  • The prevalence and features of the polycystic ovary syndrome in an unselected population.  89:2745-2749. 2004
  • Hormones & you: patient information page. Hormones and obesity..  89. 2004
  • Androgen Excess in Women: Experience with over 1000 Consecutive Patients.  89:453-462. 2004
  • Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone.  88:5137-5144. 2003
  • Relationship between serum leptin concentration and low-density muscle in postmenopausal women.  88:1157-1161. 2003
  • Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children.  88:192-195. 2003
  • Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling.  87:4085-4087. 2002
  • Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children..  87:2218-2224. 2002
  • Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children.  87:2218-2224. 2002
  • Troglitazone use in polycystic ovary syndrome [4].  86:5090-5091. 2001
  • Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking..  86:5450-5456. 2001
  • Longitudinal changes in body fat in African American and Caucasian children: Influence of fasting insulin and insulin sensitivity.  86:3182-3187. 2001
  • Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropin.  86:2513-2517. 2001
  • Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin..  86:2513-2517. 2001
  • Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial.  86:1626-1632. 2001
  • Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial..  86:1626-1632. 2001
  • Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: Implications regarding defects in vesicle trafficking.  86:5450-5456. 2001
  • Weight loss is not associated hyperleptinemia in humans pancreatic cancer.  86:162-166. 2001
  • Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women.  85:4476-4480. 2000
  • Comment on extrapituitary parasellar macroadenoma in cushing's disease [1].  85:2082. 2000
  • Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.  85:48-54. 2000
  • Leptin in postmenopausal women: Influence of hormone therapy, insulin, and fat distribution.  85:1770-1775. 2000
  • The skin produces urocortin.  85:815-823. 2000
  • Comment on extrapituitary parasellar macroadenoma in Cushing's disease..  85:2082. 2000
  • Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution..  85:1770-1775. 2000
  • Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin.  85:3582-3588. 2000
  • Impact of architectural disruption on adrenocortical steroidogenesis in vitro..  84:1017-1021. 1999
  • Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level..  84:946-950. 1999
  • Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans.  84:3579-3585. 1999
  • Hypertension in women.  84:1862-1866. 1999
  • Impact of architectural disruption on adrenocortical steroidogenesis in vitro.  84:1017-1021. 1999
  • Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.  84:946-950. 1999
  • Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.  83:2317-2323. 1998
  • Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study.  83:3078-3082. 1998
  • Characterization of corticotropin-releasing hormone (CRH) in human skin.  83:1020-1024. 1998
  • Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).  83:1976-1987. 1998
  • The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women.  83:519-524. 1998
  • Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study..  83:3078-3082. 1998
  • Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis..  83:2317-2323. 1998
  • Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)..  83:1976-1987. 1998
  • Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.  83:3219-3224. 1998
  • Serum leptin and energy expenditure in children..  82:4149-4153. 1997
  • Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children.  82:2148-2152. 1997
  • Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children..  82:2148-2152. 1997
  • The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.  82:1293-1300. 1997
  • The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure..  82:1293-1300. 1997
  • Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.  82:479-485. 1997
  • Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate.  82:465-472. 1997
  • Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism..  82:479-485. 1997
  • Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate..  82:465-472. 1997
  • Aging alters zonation in the adrenal cortex of men.  82:3898-3901. 1997
  • Serum leptin and energy expenditure in children.  82:4149-4153. 1997
  • Role of the β3-adrenergic receptor locus in obesity and noninsulin- dependent diabetes among members of Caucasian families with a diabetic sibling pair.  81:4422-4427. 1996
  • ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin.  81:2746-2749. 1996
  • ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin..  81:2746-2749. 1996
  • Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles..  80:2437-2446. 1995
  • Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells..  80:1027-1031. 1995
  • Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.  80:400-405. 1995
  • Erratum: Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells (Journal of Clinical Endocrinology and Metabolism (1995) 80 (1027-1031)).  80:1971. 1995
  • Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children.  80:172-178. 1995
  • Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells.  80:1027-1031. 1995
  • Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study.  80:3406-3411. 1995
  • Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles.  80:2437-2446. 1995
  • Clinical review 56: nonclassic adrenal hyperplasia: Current concepts.  78:810-815. 1994
  • Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues.  78:234-236. 1994
  • Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.  79:1747-1751. 1994
  • Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles..  77:286-289. 1993
  • Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles.  77:286-289. 1993
  • Adrenocorticotropin interferes with transforming growth factor-β-induced growth inhibition of neocortical cells from the human fetal adrenal gland.  75:1519-1521. 1992
  • Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.  73:1327-1331. 1991
  • The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women.  72:1025-1030. 1991
  • Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling time.  70:1273-1279. 1990
  • Changes in Endocrine Function after Adrenal Medullary Transplantation to the Central Nervous System.  71:773-776. 1990
  • On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.  70:431-436. 1990
  • 21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and Diagnosis.  69:577-584. 1989
  • CV 205–502 treatment of hyperprolactinemia.  68:336-339. 1989
  • Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary.  66:804-810. 1988
  • The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1..  65:1098-1101. 1987
  • In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-Deficient individuals.  64:98-105. 1987
  • Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study.  60:698-705. 1985
  • Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.  60:559-568. 1985
  • Thyrotropin (TSH)-induced hyperthyroidism: Response of TSH to dopamine and its agonists.  58:255-261. 1984
  • Umbilical Cord Plasma Levels of Dehydroepiandrosterone Sulfate during Human Gestation.  54:1216-1220. 1982
  • Diurnal patterns and regulation of cortisol secretion in pregnancy.  51:466-472. 1980
  • Plasma angiotensin converting enzyme activity in mother and fetus.  46:434-439. 1978
  • Effects of ph and enzyme inhibitors on apparent generation of angiotensin i in human plasma.  39:965-968. 1974
  • International Standard Serial Number (issn)

  • 0021-972X
  • Electronic International Standard Serial Number (eissn)

  • 0021-972X
  • 1945-7197